Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zhejiang Hisun Sulikang Biotechnology

Request full access

Specialty medical foods for digestive and metabolic disorders

ChinaFounded 2015

About Zhejiang Hisun Sulikang Biotechnology

Zhejiang Hisun Sulikang Biotechnology Co., Ltd. is a producer of special medical and functional foods for individuals with digestive disorders, metabolic challenges, or other special disease states. The company was established in October 2015 as a wholly-owned subsidiary of the A-share listed company Zhejiang Hisun Pharmaceutical, which was founded in 1956. Hisun Sulikang was created to extend the parent company's reach into the health industry, leveraging its research and development teams and production capabilities.

The company's product line focuses on foods for special medical purposes (FSMPs), health supplements, and functional foods, available in forms like solid and liquid beverages, tablets, and freeze-dried products. One of its key achievements was the development of Yinengjia®, a protein component formula for special medical purposes, which received the first domestic registration certificate for a protein component FSMP from the State Administration for Market Regulation. The firm operates an 8,000-square-meter GMP-standardized factory with 16 production lines, including advanced automated and specialized medical food production lines.

Hisun Sulikang has secured multiple rounds of funding to support its growth. In July 2023, the company completed a financing round of over 100 million RMB from investors including Bell Capital, Yuanquan Industrial, and the team of Yang Jiyong, who serves as the company's General Manager. This was followed by another round in April 2024 for tens of millions of RMB. The company's business model is centered on the research, production, and sale of its specialized food products, serving a market that requires specially processed and formulated nutrition.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
14.7/100

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Apr 2024 $2.8M $69M Plank Road Capital ↗
SERIES B✓Equity / VC Jul 2023 $14M $55M Eastern Bell Capital · Source Industry ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zhejiang Hisun Sulikang Biotechnology in its local ecosystem

Live from Dealroom

The Zhejiang Hisun Sulikang Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Zhejiang Hisun Pharmaceutical
  • Eastern Bell Capital
  • Source Industry

Series B and later1 investor entered at this stage

  • Plank Road Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zhejiang Hisun Sulikang Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zhejiang Hisun Sulikang Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.